SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-218388
Filing Date
2012-05-08
Accepted
2012-05-08 16:05:27
Documents
3
Period of Report
2012-05-03
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d348919d8k.htm 8-K 17459
2 PRESS RELEASE d348919dex991.htm EX-99.1 59705
3 GRAPHIC g348919gra.jpg GRAPHIC 11159
  Complete submission text file 0001193125-12-218388.txt   93856
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34828 | Film No.: 12821445
SIC: 2834 Pharmaceutical Preparations